Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases

被引:74
作者
Keeling, Kim M. [1 ]
Bedwell, David M. [1 ]
机构
[1] Univ Alabama Birmingham, Dept Microbiol, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA
关键词
MESSENGER-RNA DECAY; TRANSLATIONAL TERMINATION EFFICIENCY; PREMATURE STOP MUTATIONS; CYSTIC-FIBROSIS PATIENTS; ALPHA-L-IDURONIDASE; DYSTROPHIN EXPRESSION; CRYSTAL-STRUCTURE; READ-THROUGH; IN-VITRO; AMINOGLYCOSIDE;
D O I
10.1002/wrna.95
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Suppression therapy is a treatment strategy for genetic diseases caused by nonsense mutations. This therapeutic approach utilizes pharmacological agents that suppress translation termination at in-frame premature termination codons (PTCs) to restore translation of a full-length, functional polypeptide. The efficiency of various classes of compounds to suppress PTCs in mammalian cells is discussed along with the current limitations of this therapy. We also elaborate on approaches to improve the efficiency of suppression that include methods to enhance the effectiveness of current suppression drugs and the design or discovery of new, more effective suppression agents. Finally, we discuss the role of nonsense-mediated mRNA decay (NMD) in limiting the effectiveness of suppression therapy, and describe tactics that may allow the efficiency of NMD to be modulated in order to enhance suppression therapy. (c) 2011 John Wiley & Sons, Ltd. WIREs RNA 2011 2 837-852 DOI: 10.1002/wrna.95
引用
收藏
页码:837 / 852
页数:16
相关论文
共 97 条
[1]   The ATM-related kinase, hSMG-1, bridges genome and RNA surveillance pathways [J].
Abraham, RT .
DNA REPAIR, 2004, 3 (8-9) :919-925
[2]   A faux 3′-UTR promotes aberrant termination and triggers nonsense-mediated mRNA decay [J].
Amrani, N ;
Ganesan, R ;
Kervestin, S ;
Mangus, DA ;
Ghosh, S ;
Jacobson, A .
NATURE, 2004, 432 (7013) :112-118
[3]   Negamycin restores dystrophin expression in skeletal and cardiac muscles of mdx mice [J].
Arakawa, M ;
Shiozuka, M ;
Nakayama, Y ;
Hara, T ;
Hamada, M ;
Kondo, S ;
Ikeda, D ;
Takahashi, Y ;
Sawa, R ;
Nonomura, Y ;
Sheykholeslami, K ;
Kondo, K ;
Kaga, K ;
Kitamura, T ;
Suzuki-Miyagoe, Y ;
Takeda, S ;
Matsuda, R .
JOURNAL OF BIOCHEMISTRY, 2003, 134 (05) :751-758
[4]  
ASHTON LJ, 1992, AM J HUM GENET, V50, P787
[5]   Overriding standard decoding:: Implications of recoding for ribosome function and enrichment of gene expression [J].
Atkins, JF ;
Baranov, PV ;
Fayet, O ;
Herr, AJ ;
Howard, MT ;
Ivanov, IP ;
Matsufuji, S ;
Miller, WA ;
Moore, B ;
Prère, MF ;
Willis, NM ;
Zhou, J ;
Gesteland, RF .
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 2001, 66 :217-232
[6]   Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124 [J].
Auld, Douglas S. ;
Lovell, Scott ;
Thorne, Natasha ;
Lea, Wendy A. ;
Maloney, David J. ;
Shen, Min ;
Rai, Ganesha ;
Battaile, Kevin P. ;
Thomas, Craig J. ;
Simeonov, Anton ;
Hanzlik, Robert P. ;
Inglese, James .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (11) :4878-4883
[7]   Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression [J].
Auld, Douglas S. ;
Thorne, Natasha ;
Maguire, William F. ;
Inglese, James .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (09) :3585-3590
[8]   Crystal Structure of the Eukaryotic Ribosome [J].
Ben-Shem, Adam ;
Jenner, Lasse ;
Yusupova, Gulnara ;
Yusupov, Marat .
SCIENCE, 2010, 330 (6008) :1203-1209
[9]   NMD: RNA biology meets human genetic medicine [J].
Bhuvanagiri, Madhuri ;
Schlitter, Anna M. ;
Hentze, Matthias W. ;
Kulozik, Andreas E. .
BIOCHEMICAL JOURNAL, 2010, 430 :365-377
[10]   Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model [J].
Brendel, Cornelia ;
Belakhov, Valery ;
Werner, Hauke ;
Wegener, Eike ;
Gaertner, Jutta ;
Nudelman, Igor ;
Baasov, Timor ;
Huppke, Peter .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2011, 89 (04) :389-398